graphite-investing Graphite One Signs US$ 4.8 million Loan Agreement, to Fund Completion of Pre-Feasibility Study
graphite-investing Graphite One Announces Closing Second Tranche of Financing and Awarding of Options
graphite-investing Graphite One Announces Initial Shipment of Material to U.S. Industrial Processing Partner
graphite-investing Graphite One Closes First Tranche of Private Placement Completes $1.8 Million Financing
graphite-investing Graphite One Increases Tonnage, Grade and Contained Graphite of Measured and Indicated, and Inferred Resources in Updated Mineral Resource Estimate
graphite-investing Graphite One Drills 16.3 Metres Of 11.93% Graphite, At Graphite Creek Project, Alaska
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound